We are proud to have been named as one of the top 100 health and medtech startups for 2020 by HexGn – an international group of investors, based in New Delhi.
HexGn’s network of more than 20 000 investors delivers global reports on the latest investment opportunities, and offers an accelerator programme for start-up businesses to maxmise potential.
It is an honour to be featured as one of the group’s top 100 health & medtech startups for 2020. Our work in developing the world’s first saliva-based RDT for malaria will revolutionise the way the disease is detected and, more importantly, save lives.
Keep up to date with our latest developments here, and learn more about HexGn on the group’s website.
Early detection, early diagnosis, end malaria.
Please follow and like us: